WALTHAM, Mass. and BOULDER, Colo., Jan. 30, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: COGT), a biotechnology company focused on ...

New York-based VJ Group announced the launch of its newest venture, VJ Bio, a biotech company dedicated to creating an ...

will host a fireside chat at the Guggenheim Biotech Conference in New York City as follows: The live and archived webcast will be accessible from the Company’s website at www.anipharmaceuticals ...

I-Mab (NASDAQ: IMAB) (the Company), a U.S.-based, global biotech company, focused on the development of precision ...

Registration Now Open for Pharmacovigilance Europe Conference 2025: Innovation, Integration and Advancing Global Pharmacovigilance In The Digital Age (London, United Kingdom - May 21-22, 2025) - ...

(Nasdaq: RZLT) (“Rezolute” or the “Company”), a late-stage biopharmaceutical company dedicated to developing transformative therapies for rare diseases with serious unmet needs, today announced that ...

Tenax Therapeutics’ management will also participate in one-on-one investor meetings. To request a one-on-one meeting at the conference, please contact your Guggenheim representative. The live and ...

The biotech sector in 2025 presents a landscape brimming with both opportunities and challenges. The industry is being shaped ...

announced today that Company management will participate in fireside chats at following conferences: Guggenheim SMID Cap Biotech Conference Date: Thursday, February 6, 2025Time: 1pm ET / 7pm ...

today announced that management will participate in the Guggenheim SMID Cap Biotech Conference, taking place February 5-6, 2025, in New York City. Management will be participating in one-on-one ...

today announced that the Company will participate in a fireside chat at the Guggenheim SMID Cap Biotech Conference, which is taking place from February 5-6, 2025, in New York, NY. Tenax ...